Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Neijt

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1984
Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5J P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 2001
[Diverse expression of multiple endocrine neoplasia type 1]K M Dreijerink, J F Roijers, J M Jansen-Schillhorn van Veen, et al.
NMR in Biomedicine|June 1, 1989
31P NMR study of the impact of dietary manipulation on tumor metabolism and response to methotrexateP E Sijens, C J van Echteld, J P Neijt, et al.
The American Journal of Medicine|June 1, 1987
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideH I Harinck, O L Bijvoet, A S Plantingh, et al.
British Journal of Cancer|September 22, 1998
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of CancerR de Wit, G Stoter, D T Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II clinical trial of doxifluridine in patients with advanced ovarian cancerA T van Oosterom, W W ten Bokkel Huinink, M E van der Burg, et al.
Studies in Health Technology and Informatics|March 21, 2000
A development protocol for a diagnostic DSSY L O, W J ter Burg, E W ter Braak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary resultsP H Willemse, M E vd Burg, A vd Gaast, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activityE E Voest, J P Neijt, J E Keunen, et al.
Cancer|April 1, 1984
Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinomaJ P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1984
Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5J P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 2001
[Diverse expression of multiple endocrine neoplasia type 1]K M Dreijerink, J F Roijers, J M Jansen-Schillhorn van Veen, et al.
NMR in Biomedicine|June 1, 1989
31P NMR study of the impact of dietary manipulation on tumor metabolism and response to methotrexateP E Sijens, C J van Echteld, J P Neijt, et al.
The American Journal of Medicine|June 1, 1987
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideH I Harinck, O L Bijvoet, A S Plantingh, et al.
British Journal of Cancer|September 22, 1998
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of CancerR de Wit, G Stoter, D T Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II clinical trial of doxifluridine in patients with advanced ovarian cancerA T van Oosterom, W W ten Bokkel Huinink, M E van der Burg, et al.
Studies in Health Technology and Informatics|March 21, 2000
A development protocol for a diagnostic DSSY L O, W J ter Burg, E W ter Braak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary resultsP H Willemse, M E vd Burg, A vd Gaast, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activityE E Voest, J P Neijt, J E Keunen, et al.
Cancer|April 1, 1984
Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinomaJ P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Pageof 10